Summary
- Current Price
- As of today, LYRA price is $0.49, unchanged in the most recent trading session on
- Current Price All-Time High
- LYRA price is currently -99.96% below its historical high of $1,100.00 set on
- Market Cap
- LYRA current market cap is $870K, down -88.71% year-over-year
- PE Ratio
- LYRA PE ratio is unknown
- Revenue
- LYRA current annual revenue is $398.00K, down -74.05% year-over-year
- Next Earnings
- As of today, the next earnings release for LYRA has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Lyra Therapeutics, Inc. |
| Ticker | NASDAQ: LYRA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | lyratherapeutics.com |
| Employees | 30 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.49 | ||
| Price, 1D Change | 0.00% | |
| $870K | ||
| - | ||
| - | ||
| 0.71 | ||
| $398K | ||
| Revenue, 1Y Change | -74.05% | |
| -$18.62 | ||
| EPS, 1Y Change | +74.05% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:50 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$18.62 | ||
| EPS Estimate | N/A | -$7.02 |
| EPS Est. Change | N/A | +62.29% |
| $398.00K | ||
| Revenue Estimate | N/A | $700.00K |
| Revenue Est. Change | N/A | +75.88% |
| $0.49 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.31 | -$1.26 | +3.93% | |
| -$1.28 | -$71.75 | -5,527.25% | |
| - | -$18.62 | - | |
| -$7.02 | N/A | +62.29% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.73M | $1.56M | -9.94% | |
| $1.52M | $1.53M | +0.69% | |
| - | $398.00K | - | |
| $700.00K | N/A | +75.88% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -91.62% | ||
| -99.51% | ||
| -88.71% | ||
| -98.64% | ||
| -74.05% | ||
| -70.80% | ||
| +74.05% | ||
| -918.25% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.49 | ||
| $4.92 | ||
| SMA 200 vs Price | +903.88% | |
| $1.24 | ||
| SMA 50 vs Price | +151.93% | |
| 0.71 | ||
| $0.14 | ||
| 27.44 | ||
| 154.79% | ||
| 342.58% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $398.00K | ||
| -$18.62 | ||
| -$61.00K | ||
| -15.33% | ||
| -$29.55M | ||
| -7,425.38% | ||
| -$28.92M | ||
| -7,266.08% | ||
| -$29.09M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -2.82 | ||
| 1.71 | ||
| 1.71 | ||
| - | ||
| 2 | ||
| -19.27 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 2.19 | ||
| -0.08 | ||
| -0.52 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$10.72M | ||
| $15.89M | ||
| $36.11M | ||
| $16.27M | ||
| $46.83M | ||
| $9.52M | ||
| $30.26M | ||
| $4.82M | ||
| $663.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $29.32M | ||
| $29.49M | ||
| $459.00K | ||
| $0.00 | ||
| $459.00K | ||
| $0.00 | ||
| $11.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$28.86M | ||
| -$98.00K | ||
| $4.27M | ||
| $116.00K | ||
| -$28.98M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald | ||
| Cantor Fitzgerald | ||
| Jefferies | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with LYRA
FAQ
What is the ticker symbol for Lyra Therapeutics, Inc.?
The ticker symbol for Lyra Therapeutics, Inc. is NASDAQ:LYRA
Does Lyra Therapeutics, Inc. pay dividends?
No, Lyra Therapeutics, Inc. does not pay dividends
What sector is Lyra Therapeutics, Inc. in?
Lyra Therapeutics, Inc. is in the Healthcare sector
What industry is Lyra Therapeutics, Inc. in?
Lyra Therapeutics, Inc. is in the Biotechnology industry
What country is Lyra Therapeutics, Inc. based in?
Lyra Therapeutics, Inc. is headquartered in United States
When did Lyra Therapeutics, Inc. go public?
Lyra Therapeutics, Inc. initial public offering (IPO) was on May 1, 2020
Is Lyra Therapeutics, Inc. in the S&P 500?
No, Lyra Therapeutics, Inc. is not included in the S&P 500 index
Is Lyra Therapeutics, Inc. in the NASDAQ 100?
No, Lyra Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Lyra Therapeutics, Inc. in the Dow Jones?
No, Lyra Therapeutics, Inc. is not included in the Dow Jones index
When was Lyra Therapeutics, Inc. last earnings report?
Lyra Therapeutics, Inc.'s most recent earnings report was on November 12, 2025
When does Lyra Therapeutics, Inc. report earnings?
The date for Lyra Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- LYRA Official Website lyratherapeutics.com
- LYRA Profile on Yahoo Finance finance.yahoo.com/quote/LYRA
- LYRA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lyra